MNKD Market Cap History
Below is a table of the MNKD market cap history going back to 3/3/2017:

Date MNKD Market Cap
3/3/2017203.90M
3/10/2017186.76M
5/5/201780.81M
8/1/2017132.95M
10/31/2017385.41M
2/9/2018314.42M
4/24/2018242.24M
7/17/2018241.72M
10/22/2018298.45M
2/14/2019260.41M
4/15/2019304.21M
7/16/2019206.68M
10/31/2019270.39M
2/13/2020312.07M
4/13/2020247.24M
7/13/2020378.14M
10/26/2020483.81M
2/12/20211.34B
4/30/20211.14B
7/30/20211.02B
10/29/20211.18B
2/11/20221.02B
4/29/2022790.53M
7/29/2022887.82M
10/28/2022918.55M

Also see: MNKD Shares Outstanding History
and MNKD YTD Return
MNKD Historical Market Cap:
+30.50% CAGR
MNKD Historical Market Cap: +30.50% CAGR

Mouse over chart for data details
3/3/2017 ...10/28/2022
MannKind is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Co.'s primary product, Afrezza (insulin human) Inhalation Powder, is an inhaled insulin indicated to improve glycemic control in adults with diabetes. Afrezza consists of a dry powder formulation of human insulin delivered from a small portable inhaler. Co. collaborates with United Therapeutics to develop an inhaled formulation of treprostinil known as Tyvaso DPI. We show 25 historical shares outstanding datapoints in our MNKD shares outstanding history coverage, used to compute MNKD market cap on those dates.

Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing MNKD market cap history over the course of time is important for investors interested in comparing MNKD's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of MNKD versus a peer is one thing; comparing MNKD market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like MNKD can fluctuate over the course of history. With this page we aim to empower investors researching MNKD by allowing them to research the MNKD market cap history.
Quotes delayed 20 minutes

Email EnvelopeFree MNKD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: The Importance of Market Cap


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MannKind (MNKD) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:

MNLO Market Cap History
MNOV Market Cap History
MNPR Market Cap History
MNTA Market Cap History
MODD Market Cap History
MODV Market Cap History
MOH Market Cap History
MORF Market Cap History
MOTS Market Cap History
MOVE Market Cap History
More Healthcare companies »

 

MNKD Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.